SpringWorks Therapeutics (SWTX) closed the last trading session at $34.71, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $66.88 indicates a 92.7% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $9.69. While the lowest estimate of $52 indicates a 49.8% increase from the current price level, the most optimistic ...